Selected research
Industry Growth & Trends
Global Tumor Detection Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Tumor Detection Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Tumor Detection Services market include Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta and Bio-Techne, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tumor Detection Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tumor Detection Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor Detection Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor Detection Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Tumor Detection Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tumor Detection Services Market by Company
Nonacus
Natera
Penn Medicine
Amadix
Oncologica
Rarecells
GRAIL
Elypta
Bio-Techne
iCAD
Dxcover
Caris Life Sciences
Novocure
Circulogene
Guardant Health
Veracyte
Haystack Oncology
Foundation Medicine
Tumor Detection Services Segment by Type
Non-Invasive Examination
Invasive Examination
Tumor Detection Services Segment by Application
Adults
Children
Tumor Detection Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Detection Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Detection Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Detection Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tumor Detection Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Non-Invasive Examination
- Invasive Examination
Applications
- Adults
- Children
Companies covered
- Nonacus
- Natera
- Penn Medicine
- Amadix
- Oncologica
- Rarecells
- GRAIL
- Elypta
- Bio-Techne
- iCAD
- Dxcover
- Caris Life Sciences
- Novocure
- Circulogene
- Guardant Health
- Veracyte
- Haystack Oncology
- Foundation Medicine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Tumor Detection Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Tumor Detection Services Market Size by Region (2021-2032)
- 1.4.1 Global Tumor Detection Services Market Size by Region (2021-2026)
- 1.4.2 Global Tumor Detection Services Market Size by Region (2027-2032)
- 1.5 Key Regions Tumor Detection Services Market Size (2021-2032)
- 1.5.1 North America Tumor Detection Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Tumor Detection Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Tumor Detection Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Tumor Detection Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Tumor Detection Services Market Size Growth Rate (2021-2032)
2 Tumor Detection Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Non-Invasive Examination
- 2.1.2 Invasive Examination
- 2.2 Global Tumor Detection Services Market Size by Type
- 2.2.1 Global Tumor Detection Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Tumor Detection Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Tumor Detection Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Tumor Detection Services Market Size by Regions
- 2.3.1 North America Tumor Detection Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Tumor Detection Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Tumor Detection Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Tumor Detection Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Tumor Detection Services Market Size Breakdown by Type (2021-2026)
3 Tumor Detection Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Adults
- 3.1.2 Children
- 3.2 Global Tumor Detection Services Market Size by Application
- 3.2.1 Global Tumor Detection Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Tumor Detection Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Tumor Detection Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Tumor Detection Services Market Size by Regions
- 3.3.1 North America Tumor Detection Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Tumor Detection Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Tumor Detection Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Tumor Detection Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Tumor Detection Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Tumor Detection Services Industry Trends
- 4.2 Tumor Detection Services Industry Drivers
- 4.3 Tumor Detection Services Industry Opportunities and Challenges
- 4.4 Tumor Detection Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Tumor Detection Services Revenue (2021-2026)
- 5.2 Global Tumor Detection Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Tumor Detection Services Key Company Headquarters & Area Served
- 5.4 Global Tumor Detection Services Company, Product Type & Application
- 5.5 Global Tumor Detection Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Tumor Detection Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Tumor Detection Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Tumor Detection Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Nonacus
- 6.1.1 Nonacus Company Information
- 6.1.2 Nonacus Business Overview
- 6.1.3 Nonacus Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Nonacus Tumor Detection Services Product Portfolio
- 6.1.5 Nonacus Recent Developments
- 6.2 Natera
- 6.2.1 Natera Company Information
- 6.2.2 Natera Business Overview
- 6.2.3 Natera Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Natera Tumor Detection Services Product Portfolio
- 6.2.5 Natera Recent Developments
- 6.3 Penn Medicine
- 6.3.1 Penn Medicine Company Information
- 6.3.2 Penn Medicine Business Overview
- 6.3.3 Penn Medicine Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Penn Medicine Tumor Detection Services Product Portfolio
- 6.3.5 Penn Medicine Recent Developments
- 6.4 Amadix
- 6.4.1 Amadix Company Information
- 6.4.2 Amadix Business Overview
- 6.4.3 Amadix Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Amadix Tumor Detection Services Product Portfolio
- 6.4.5 Amadix Recent Developments
- 6.5 Oncologica
- 6.5.1 Oncologica Company Information
- 6.5.2 Oncologica Business Overview
- 6.5.3 Oncologica Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Oncologica Tumor Detection Services Product Portfolio
- 6.5.5 Oncologica Recent Developments
- 6.6 Rarecells
- 6.6.1 Rarecells Company Information
- 6.6.2 Rarecells Business Overview
- 6.6.3 Rarecells Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Rarecells Tumor Detection Services Product Portfolio
- 6.6.5 Rarecells Recent Developments
- 6.7 GRAIL
- 6.7.1 GRAIL Company Information
- 6.7.2 GRAIL Business Overview
- 6.7.3 GRAIL Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GRAIL Tumor Detection Services Product Portfolio
- 6.7.5 GRAIL Recent Developments
- 6.8 Elypta
- 6.8.1 Elypta Company Information
- 6.8.2 Elypta Business Overview
- 6.8.3 Elypta Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Elypta Tumor Detection Services Product Portfolio
- 6.8.5 Elypta Recent Developments
- 6.9 Bio-Techne
- 6.9.1 Bio-Techne Company Information
- 6.9.2 Bio-Techne Business Overview
- 6.9.3 Bio-Techne Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Bio-Techne Tumor Detection Services Product Portfolio
- 6.9.5 Bio-Techne Recent Developments
- 6.10 iCAD
- 6.10.1 iCAD Company Information
- 6.10.2 iCAD Business Overview
- 6.10.3 iCAD Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 iCAD Tumor Detection Services Product Portfolio
- 6.10.5 iCAD Recent Developments
- 6.11 Dxcover
- 6.11.1 Dxcover Company Information
- 6.11.2 Dxcover Business Overview
- 6.11.3 Dxcover Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Dxcover Tumor Detection Services Product Portfolio
- 6.11.5 Dxcover Recent Developments
- 6.12 Caris Life Sciences
- 6.12.1 Caris Life Sciences Company Information
- 6.12.2 Caris Life Sciences Business Overview
- 6.12.3 Caris Life Sciences Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Caris Life Sciences Tumor Detection Services Product Portfolio
- 6.12.5 Caris Life Sciences Recent Developments
- 6.13 Novocure
- 6.13.1 Novocure Company Information
- 6.13.2 Novocure Business Overview
- 6.13.3 Novocure Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Novocure Tumor Detection Services Product Portfolio
- 6.13.5 Novocure Recent Developments
- 6.14 Circulogene
- 6.14.1 Circulogene Company Information
- 6.14.2 Circulogene Business Overview
- 6.14.3 Circulogene Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Circulogene Tumor Detection Services Product Portfolio
- 6.14.5 Circulogene Recent Developments
- 6.15 Guardant Health
- 6.15.1 Guardant Health Company Information
- 6.15.2 Guardant Health Business Overview
- 6.15.3 Guardant Health Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Guardant Health Tumor Detection Services Product Portfolio
- 6.15.5 Guardant Health Recent Developments
- 6.16 Veracyte
- 6.16.1 Veracyte Company Information
- 6.16.2 Veracyte Business Overview
- 6.16.3 Veracyte Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Veracyte Tumor Detection Services Product Portfolio
- 6.16.5 Veracyte Recent Developments
- 6.17 Haystack Oncology
- 6.17.1 Haystack Oncology Company Information
- 6.17.2 Haystack Oncology Business Overview
- 6.17.3 Haystack Oncology Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Haystack Oncology Tumor Detection Services Product Portfolio
- 6.17.5 Haystack Oncology Recent Developments
- 6.18 Foundation Medicine
- 6.18.1 Foundation Medicine Company Information
- 6.18.2 Foundation Medicine Business Overview
- 6.18.3 Foundation Medicine Tumor Detection Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Foundation Medicine Tumor Detection Services Product Portfolio
- 6.18.5 Foundation Medicine Recent Developments
7 North America
- 7.1 North America Tumor Detection Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Tumor Detection Services Market Size by Country (2021-2026)
- 7.3 North America Tumor Detection Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Tumor Detection Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Tumor Detection Services Market Size by Country (2021-2026)
- 8.3 Europe Tumor Detection Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Tumor Detection Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Tumor Detection Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Tumor Detection Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Tumor Detection Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Tumor Detection Services Market Size by Country (2021-2026)
- 10.3 South America Tumor Detection Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Tumor Detection Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Tumor Detection Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Tumor Detection Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst